Professional Documents
Culture Documents
Science
Cancer
Infectious diseases
Genetics
Surrogate Biomarkers
Single cell
Type
Sequence
Quantity
Quality
Modifications
Split
sample by
dilution
dPCR 20 1 l
reactions
Infectious diseases
Work packages
1. Higher order methods
2. Measurement challenges
associated with emerging
methodologies.
3. Near-patient testing
4. Development of a
reference measurement
framework to improve
current clinical approaches
Model diseases
. Human cytomegalovirus,
Influenza, Tuberculosis and
chronic obstructive
pulmonary disease
Introduction
Molecular Microbial Profiling
Human
Human
microbiome
microbiome
8,000,000+
8,000,000+
genes
genes
Human
genome
23,000 genes
11 >360 times
12
The Complications
High level of complexity of information offered by
microbial molecular profiling methods
Poses a considerable challenge during analytical
standardisation
Disparate methods could cause problems
So how can control materials help?
13
14
Previous Work
16
Microbial Metagenomics
Mass based
Method A
Method B
Neisseria meningitidis
Streptococcus pneumoniae
Staphylococcus aureus
Klebsiella pneumoniae
Streptococcus pyogenes
Streptococcus agalactiae
Enterococcus faecalis
Escherichia coli
Pseudomonas aeruginosa
Acinetobacter baumannii
Study
Aim: to perform a comprehensive investigation into the
inherent error in profiling microbial communities
Use the control material (metagenomic control material
MCM) for community analysis which was already
prepared
Characterise control material using two independent
methods dPCR and fluorescence
Can use the MCM to investigate errors when performing
different sequencing strategies (amplicon v shotgun)
Compare the relative abundances of the component
organisms of the MCM as determined by dPCR,
18
fluorescence and next generation sequencing
methods
19
20
Conclusions
dPCR offers a simple method for providing confidence
when measuring control materials
All sequencing methods performed comparably
Good agreement between sequencing methods and
dPCR (WGS demonstrating very high reproducibility)
Any discrepancy between abundances were in general <
3 fold
Care should be taken when comparing small differences;
need to apply control material
Provides a foundation for future work looking at microbial
abundances in a community
Future work looking at impact of extraction 21methods
22
Test Cases
Gammon samples stored at +4oC and -20oC for several
weeks
Freeze-dried chicken samples (LGC Standards)
Perform 16S rDNA sequencing on the Roche GS Junior
24
25
26
28
Molecular vs Culture
P Q01.1 Report on the first pilot study- Establishing
Comparability for Microbial Culture Quantitation (NMIA)
Dr. Dean Clarke, NMIA
gDNA materials
Available from IRMM for
E. coli O157, (strain EDL 933)
L. monocytogenes (strain 4B, NCTC 11994)
Gene dosage
Replication
Multicopy genes (16S rDNA)
Epigenetics
Methylation
Bacterial replication
www.pasteur.fr
33
C A
B
A
C
34
Chromosomal Targets
E. coli has large genome
Target four regions
35
rrsH
B
rrs
E
rrs
E. coli gDNA
or
iC
sA
rr
rrs
0kb
520kb
4680kb
1040kb
4160kb
rrsD
1560kb
3640kb
2080kb
3120kb
rrsG
2600kb
E. coli CFT073
di
f
ui
dA
Clockwise
= Strand +
Anticlockwise
= Strand -
36
http://www.ncbi.nlm.nih.gov/nucleotide/26111730?report=genbank&log$=nuclalign&blast_rank=74&RID=KW9A1N24016
http://www.ecogene.org/old/genemap/map.php?search_topic=132
Questions?
How does chromosomal location effect result (qPCR,
dPCR)
Is this similar between
Strains
Preparations/Laboratories
37
E. coli gDNA
Three different E. coli strains
O157:H7, (strain EDL 933). Supplied by IRMM
O157:H7, (strain EDL 931), Supplied by NIMC
CFT073, Supplied by ATCC
38
E. coli gDNA
3000
2500
2000
Estimated copies
O157:
933
1500
1000
500
0
oriC
dif
uidA
16S
Target gene
39
E. coli gDNA
3000
2500
2000
Estimated copies
CFT0
73
1500
1000
500
0
oriC
dif
uidA
16S
Target gene
40
E. coli gDNA
600
500
400
Mean Est
CFT0
73
300
200
100
0
oriC
dif
uidA
16S
Target gene
41
Absolute Quantification
Concordance between assays is very impressive
dPCR has the potential to improve microbial molecular
measurement
Do we need to assign a value to gDNA extracts?
Other things to consider
42
Other considerations
How do we standardise
qPCR/amplicon sequencing/shotgun?
Different laboratories?
44
Acknowledgements
LGC
Jim Huggett, Carole Foy, Tan Temisak, Nicholas Redshaw
University of Exeter
David Studholme, Thomas Laver
St. Georges University of London
Philip Butcher, Ken Laing
Great Ormond Street Hospital
Kathryn Harris
National Measurement Institute China
Lianhua Dong
45
46